News
SIDS surprise: Study finds that infant boys are more easily aroused from sleep than girls
July 31, 2010 10:37 pm | by EurekAlert | Comments(American Academy of Sleep Medicine) At 2 to 4 weeks of age, the mean strength of a pulsatile air-jet stimulus that was required to induce arousal during quiet sleep was significantly lower in male infants than female infants. At 2 to 3 months of age when the SIDS risk peaks, this...
Short and long sleep durations are independent risk factors for cardiovascular disease
July 31, 2010 9:31 pm | by EurekAlert | Comments(American Academy of Sleep Medicine) The risk of any cardiovascular disease for adults who reported sleeping five hours per day or less was more than two times higher than that of people who reported a daily sleep duration of seven hours (adjusted odds ratio = 2.20). Participants who...
Missing Puma reveals cancer conundrum
July 31, 2010 2:37 pm | by EurekAlert | Comments(Walter and Eliza Hall Institute) Walter and Eliza Hall Institute researchers in Melbourne, Australia, have made a discovery that has upended scientists' understanding of programmed cell death and its role in tumor formation.
GT solar acquires sapphire producer crystal systems
July 31, 2010 10:34 am | by I-Micronews | CommentsEntry into fast growing sapphire market creates new revenue opportunities
Consumer Information on: OraQuick HCV Rapid Antibody Test - P080027
July 30, 2010 5:32 pm | by U.S. Food & Drug Administration | CommentsThe OraQuick HCV Rapid Antibody Test is used to detect a patient?s exposure to the hepatitis C virus (HCV). Antibodies are proteins produced by the body to fight against foreign substances, such as viruses and bacteria. The presence of the antibodies...
Summary Information for: OraQuick HCV Rapid Antibody Test
July 30, 2010 5:32 pm | by U.S. Food & Drug Administration | CommentsLabeling, Approval Order, and Summary of Safety and Effectiveness for OraQuick HCV Rapid Antibody Test (P080027).
NICE Recommends First Device Under New Technology Pathway
July 30, 2010 5:31 pm | by U.S. Food & Drug Administration | CommentsThe UK's National Institute for Health and Clinical Excellence (NICE) has given a provisional nod to B. Braun Medical's SeQuent Please balloon catheter for use in patients with in-stent restenosis in bare metal coronary artery stents, following the recommendation of the...
FDA Extends Comment Period on Reclassification Rule
July 30, 2010 5:31 pm | by U.S. Food & Drug Administration | CommentsThe FDA is giving devicemakers more time to comment on a proposed rule that would reclassify some devices as Class II and amend the regulations to establish special controls for others.
Miracle Mineral Solution (MMS): Product as consumed produces a potent bleach
July 30, 2010 5:31 pm | by U.S. Food & Drug Administration | CommentsProduct sold online as a dietary supplement. When consumed as instructed, produces an industrial bleach that can cause serious harm to health.
Afluria (CSL Ltd.) Influenza Virus Vaccine: Label Change - Risk of Fever and Febrile Seizure
July 30, 2010 5:30 pm | by U.S. Food & Drug Administration | CommentsIncreased incidence of fever and febrile seizure among young children reported in Australia, mainly among those less than 5 years of age.
3M, Vosschemie resolve patent dispute
July 30, 2010 2:45 pm | by The Associated Press | Comments3M Co. and Vosschemie GmbH said Friday they have settled a patent infringement lawsuit that 3M filed last November.The case involves a patent 3M owns concerning its Paint Preparation Systems products. 3M manufactures and sells a disposable cup paint mixing system under its PPS brand.Vosschemie...
Perrigo Confirms Filing for Generic Version of Gynazole-1® Cream and Announcement of Patent Infringement Lawsuit by KV Pharma
July 30, 2010 12:40 pm | by Bio-Medicine.Org | CommentsALLEGAN, Mich. , July 30 /- Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for butoconazole nitrate vaginal cream, 2% and that is has notified KV Pharmaceutical Company, the owner...
FDA Approves Vaccines for the 2010-2011 Influenza Season
July 30, 2010 12:40 pm | by Bio-Medicine.Org | CommentsSILVER SPRING, Md. , July 30 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the United States . (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo: http://www.newscom....
Mylan Announces Pricing of Add-On Offering of Senior Notes
July 30, 2010 12:40 pm | by Bio-Medicine.Org | CommentsPITTSBURGH , July 30 /- Mylan Inc. (Nasdaq: MYL ) today announced that it priced $300 million aggregate principal amount of Senior Notes due 2020 at an issue price of 105.5% with a coupon of 7.875%, or an effective yield to maturity of 7.087%. The notes are being offered as additional...
WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
July 30, 2010 12:39 pm | by Bio-Medicine.Org | CommentsSHANGHAI , July 30 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States , today announced that it will release financial results for the second...
